Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-18-005569

← back to feed
Filed
Nov 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Nov 14, 2018 16.41M sh
Operating Cash Flow Q1 2019 · Sep 30, 2018 −$100.95K
Operating Cash Flow Q1 2019 · Sep 30, 2017 −$165.24K
Cash And Equivalents Q1 2019 · Sep 30, 2018 $38.63K
Cash And Equivalents Q1 2019 · Jun 30, 2018 $64.58K
Cash And Equivalents Q1 2019 · Sep 30, 2017 $1.11K
Cash And Equivalents Q1 2019 · Jun 30, 2017 $11.35K
Stockholders Equity Q1 2019 · Sep 30, 2018 −$6.07M
Stockholders Equity Q1 2019 · Jun 30, 2018 −$5.58M
Current Liabilities Q1 2019 · Sep 30, 2018 $3.18M
Current Liabilities Q1 2019 · Jun 30, 2018 $3.1M
Total Liabilities Q1 2019 · Sep 30, 2018 $6.13M
Total Liabilities Q1 2019 · Jun 30, 2018 $5.68M
Current Assets Q1 2019 · Sep 30, 2018 $59.32K
Current Assets Q1 2019 · Jun 30, 2018 $91.6K
Total Assets Q1 2019 · Sep 30, 2018 $59.32K
Total Assets Q1 2019 · Jun 30, 2018 $91.6K
Sga Expense Q1 2019 · Sep 30, 2018 $194.23K
Sga Expense Q1 2019 · Sep 30, 2017 $288.92K
Rd Expense Q1 2019 · Sep 30, 2018 $32K
Rd Expense Q1 2019 · Sep 30, 2017 $42.31K
Net Income Q1 2019 · Sep 30, 2018 −$537.3K
Net Income Q1 2019 · Sep 30, 2017 −$431.48K